Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001
Phase 2
- Conditions
- Hepatitis B
- Interventions
- Biological: VVX001Biological: Placebo
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Viravaxx AG
- Target Recruit Count
- 84
- Registration Number
- NCT03625934
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
🇦🇹Medical University of Graz, Graz, Austria
© Copyright 2025. All Rights Reserved by MedPath